Get the Stockscreener App
0.48
2.04%
-0.01
After Hours:
.48
Promis Neurosciences Inc stock is traded at $0.48, with a volume of 732.83K.
It is down -2.04% in the last 24 hours and up +9.12% over the past month.
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
See More
Previous Close:
$0.49
Open:
$0.5
24h Volume:
732.83K
Relative Volume:
0.10
Market Cap:
$24.87M
Revenue:
-
Net Income/Loss:
$-563.30K
P/E Ratio:
-2.4048
EPS:
-0.1996
Net Cash Flow:
$-22.23M
1W Performance:
-12.54%
1M Performance:
+9.12%
6M Performance:
-14.22%
1Y Performance:
-52.94%
1-Day Range:
$0.452
$0.5003
1-Week Range:
$0.452
$0.605
52-Week Range:
$0.38
$1.59
Promis Neurosciences Inc Stock (PMN) Company Profile
Name
Promis Neurosciences Inc
Sector
Industry
Phone
416-847-6898
Address
SUITE 200, 1920 YONGE STREET, TORONTO
Compare PMN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PMN
Promis Neurosciences Inc
|
0.48 | 26.37M | 0 | -563.30K | -22.23M | -0.1996 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Promis Neurosciences Inc Stock (PMN) Latest News
Will ProMIS Neurosciences Inc. (23J0) stock sustain uptrend momentumTrade Risk Summary & Short-Term High Return Ideas - newser.com
What to expect from ProMIS Neurosciences Inc. in the next 30 daysPortfolio Value Summary & Low Drawdown Investment Ideas - newser.com
What MACD and RSI say about ProMIS Neurosciences Inc.2025 Short Interest & Capital Efficiency Focused Ideas - newser.com
Is ProMIS Neurosciences Inc. stock safe for conservative investorsWeekly Market Outlook & Technical Confirmation Trade Alerts - newser.com
Custom watchlist performance reports with ProMIS Neurosciences Inc.Buy Signal & Momentum Based Trading Signals - newser.com
Can technical indicators confirm ProMIS Neurosciences Inc.’s reversalTrade Volume Summary & Growth Focused Stock Reports - newser.com
Promis Neurosciences (NASDAQ:PMN) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
Custom strategy builders for tracking ProMIS Neurosciences Inc.Earnings Overview Report & Precise Trade Entry Recommendations - newser.com
How high can ProMIS Neurosciences Inc. stock go2025 Year in Review & Risk Controlled Swing Trade Alerts - newser.com
Using data models to predict ProMIS Neurosciences Inc. stock movement2025 Momentum Check & Smart Swing Trading Techniques - newser.com
How hedge fund analytics apply to ProMIS Neurosciences Inc. stockGDP Growth & Weekly High Conviction Trade Ideas - newser.com
Can ProMIS Neurosciences Inc. (23J0) stock surprise with quarterly resultsQuarterly Profit Summary & High Accuracy Swing Trade Signals - newser.com
ProMIS Neurosciences Amends Employment Agreement with CSO - MSN
ProMIS Neurosciences Stock (PMN) Opinions on Alzheimer’s Candidate Fast Track Designation - Quiver Quantitative
Milbury Max a buys ProMis Neurosciences (PMN) shares worth $14928 - Investing.com
Will ProMIS Neurosciences Inc. (23J0) stock beat value stocksQuarterly Earnings Summary & Weekly Sector Rotation Insights - newser.com
Automated trading signals detected on ProMIS Neurosciences Inc.Trade Analysis Report & Expert Verified Stock Movement Alerts - newser.com
Predicting ProMIS Neurosciences Inc. trend using moving averages2025 Fundamental Recap & High Accuracy Swing Trade Signals - newser.com
What drives ProMIS Neurosciences Inc stock priceHealthcare Stock Analysis & Get Alerts on Stocks Set to Skyrocket - earlytimes.in
ProMIS Neurosciences Inc 23J0 Stock Analysis and ForecastPortfolio Allocation Tips & Exceptional Return Investment - earlytimes.in
Volume spikes in ProMIS Neurosciences Inc. stock – what they meanWeekly Stock Recap & Low Drawdown Momentum Ideas - newser.com
Can a trend reversal in ProMIS Neurosciences Inc. lead to recoveryVolume Spike & Weekly Chart Analysis and Trade Guides - newser.com
Breakout Move: How risky is ProMIS Neurosciences Inc. stock nowQuarterly Portfolio Report & Advanced Technical Analysis Signals - The British Mountaineering Council
Promis Neurosciences Inc Stock (PMN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Promis Neurosciences Inc Stock (PMN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Cashman Neil | Chief Scientific Officer |
Feb 10 '25 |
Buy |
0.97 |
15,000 |
14,595 |
16,617 |
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):